Literature DB >> 20930754

Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy.

Napoleone Ferrara1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20930754     DOI： 10.1038/nm1010-1107

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  52 in total

Review 1.  Age-related macular degeneration.

Authors:  Rama D Jager; William F Mieler; Joan W Miller
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

2.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Authors:  David M Brown; Peter A Campochiaro; Rishi P Singh; Zhengrong Li; Sarah Gray; Namrata Saroj; Amy Chen Rundle; Roman G Rubio; Wendy Yee Murahashi
Journal:  Ophthalmology       Date:  2010-04-09       Impact factor: 12.079

Review 3.  Targeting the tumour vasculature: insights from physiological angiogenesis.

Authors:  Alicia S Chung; John Lee; Napoleone Ferrara
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

Review 4.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Authors:  David M Brown; Peter K Kaiser; Mark Michels; Gisele Soubrane; Jeffrey S Heier; Robert Y Kim; Judy P Sy; Susan Schneider
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

6.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

Review 7.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

8.  Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

Authors:  A P Adamis; D T Shima; M J Tolentino; E S Gragoudas; N Ferrara; J Folkman; P A D'Amore; J W Miller
Journal:  Arch Ophthalmol       Date:  1996-01

9.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
View more
  77 in total

Review 1.  Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Authors:  Shom Goel; Andus Hon-Kit Wong; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

2.  CTCF-dependent chromatin insulator as a built-in attenuator of angiogenesis.

Authors:  Jianrong Lu; Ming Tang
Journal:  Transcription       Date:  2012-03-01

3.  Stability analysis of vascular endothelial growth factor in cerebrospinal fluid.

Authors:  Jun Yang; Stephen M Dombrowski; Abhishek Deshpande; Natalie Krajcir; Serge El-Khoury; Chandra Krishnan; Mark G Luciano
Journal:  Neurochem Res       Date:  2011-06-04       Impact factor: 3.996

4.  Vasoprotective effect of PDGF-CC mediated by HMOX1 rescues retinal degeneration.

Authors:  Chang He; Chen Zhao; Anil Kumar; Chunsik Lee; Mingquan Chen; Lijuan Huang; Jing Wang; Xiangrong Ren; Yida Jiang; Wei Chen; Bin Wang; Zhiqin Gao; Zheng Zhong; Zijing Huang; Fan Zhang; Bing Huang; Hao Ding; Rong Ju; Zhongshu Tang; Yizhi Liu; Yihai Cao; Xuri Li; Xialin Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

5.  Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration.

Authors:  Patrick Koenig; Chingwei V Lee; Sarah Sanowar; Ping Wu; Jeremy Stinson; Seth F Harris; Germaine Fuh
Journal:  J Biol Chem       Date:  2015-06-18       Impact factor: 5.157

Review 6.  Molecular parallels between neural and vascular development.

Authors:  Anne Eichmann; Jean-Léon Thomas
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

7.  Immunosympathectomy as the first phenotypic knockout with antibodies.

Authors:  Antonino Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-20       Impact factor: 11.205

8.  Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction.

Authors:  Norihiro Nagai; Pete Lundh von Leithner; Kanako Izumi-Nagai; Brett Hosking; Bo Chang; Ron Hurd; Peter Adamson; Anthony P Adamis; Richard H Foxton; Yin Shan Ng; David T Shima
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-20       Impact factor: 4.799

9.  Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization.

Authors:  Alexandre Dubrac; Gael Genet; Roxana Ola; Feng Zhang; Laurence Pibouin-Fragner; Jinah Han; Jiasheng Zhang; Jean-Léon Thomas; Alain Chedotal; Martin A Schwartz; Anne Eichmann
Journal:  Circulation       Date:  2015-12-09       Impact factor: 29.690

10.  Expression and Characterization of Human Vascular Endothelial Growth Factor Produced in SiHa Cells Transduced with Adenoviral Vector.

Authors:  N C Parra; R Mansilla; G Aedo; N S Vispo; E E González-Horta; I González-Chavarría; C Castillo; F Camacho; O Sánchez
Journal:  Protein J       Date:  2019-12       Impact factor: 2.371
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.